Your session is about to expire
← Back to Search
Mineral Supplement
Magnesium Supplements for Exercise Performance
N/A
Waitlist Available
Research Sponsored by Christopher Bell
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 8 days of intervention
Summary
This trial is testing if taking magnesium supplements can help athletes perform better in exercise tests. The study focuses on endurance-trained adults because they are likely to benefit the most. Magnesium is important for many body functions, and the researchers want to see if it can also improve gut health and muscle function. Magnesium is involved in numerous processes that affect muscle function including oxygen uptake, energy production, and electrolyte balance.
Who is the study for?
This trial is for adults aged 18-40 who regularly exercise, specifically competitive cyclists with a 'Good' VO2max rating. It's not for those who've taken magnesium supplements recently, are pregnant or breastfeeding, can't do vigorous exercise, have kidney disease, or use certain medications like laxatives and heartburn treatments.
What is being tested?
The study is testing whether a short-term dietary supplement of magnesium (ReMag) can boost exercise performance, improve gut health by changing the microbiome, and enhance muscle function in mitochondria compared to a placebo.
What are the potential side effects?
While the trial doesn't list specific side effects of ReMag supplementation, common ones from magnesium intake include digestive issues like diarrhea and abdominal cramping. High doses might lead to more serious problems such as irregular heartbeat.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after 8 days of intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 8 days of intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Calculation and ordination of B-diversity scores for all fecal samples to assess clustering
Comparison High-sensitivity C-reactive protein to placebo
Granulocyte-Macrophage Progenitor Cells
+20 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: ReMagExperimental Treatment1 Intervention
Liquid Lemon flavor drink containing 300 mg magnesium chloride (Regmag) consumed twice daily for 9 days
Group II: ReMag PlaceboPlacebo Group1 Intervention
Liquid Lemon flavor drink placebo comparator consumed twice daily for 9 days.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ReMag
2021
N/A
~50
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Magnesium supplementation enhances exercise performance through several key mechanisms: it improves muscle function by aiding in muscle contraction and relaxation, supports energy production by participating in ATP synthesis, and modifies gut microbiota, which can influence overall health and recovery. These effects are crucial for exercise performance patients as they can lead to improved strength, endurance, and overall physical health, making magnesium a valuable supplement to consider in their fitness regimen.
Find a Location
Who is running the clinical trial?
Christopher BellLead Sponsor
8 Previous Clinical Trials
193 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: ReMag Placebo
- Group 2: ReMag
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.